Subtle progesterone rise after the administration of the gonadotrophin-releasing hormone antagonist Cetrorelix in intracytoplasmic sperm injection cycles

Human Reproduction

Volumn 11, Issue 7, 1996, Pages 1405-1407

  Ubaldi, Filippo ^a   Albano, Carola ^a   Peukert, Manfred ^b   Riethmüller Winzen, Hilde ^b   Camus, Michel ^a   Smitz, Johan ^a   Van Steirteghem, André ^a   Devroey, Paul ^a  

^a CENTRE FOR REPRODUCTIVE MEDICINE   (Belgium)

^b ASTA MEDICA AG   (Germany)

Author keywords

Cetrorelix; Follicular phase; GnRH antagonist; Ovarian stimulation; Serum progesterone

Indexed keywords

CETRORELIX; ESTRADIOL; FOLLITROPIN; GONADORELIN ANTAGONIST; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE; PROGESTERONE;

ADULT; ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; GRANULOSA CELL; HUMAN; HUMAN EXPERIMENT; LUTEINIZING HORMONE BLOOD LEVEL; LUTEINIZING HORMONE RELEASE; MICROINJECTION; NORMAL HUMAN; OVULATION INDUCTION; PROGESTERONE BLOOD LEVEL; SPERM; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029810034     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.humrep.a019409     Document Type: Article

References (17)

1. Bustillo, M., Stern, J.J. and Coulam, C.B. (1995) Serum progesterone at the time of human chorionic gonadotrophin does not predict pregnancy in in-vitro fertilization and embryo transfer. Hum. Reprod., 10, 2862-2867.
2. Copperman, A.B., Horowitz, G.M., Kaplan, P. et al. (1995) Relationship between circulating human chorionic gonadotrophin levels and premature luteinization in cycles of controlled ovarian hyperstimulation. Fertil. Steril., 63, 1267-1271.
3. Diedrich, K., Diedrich, C., Santos, E. et al. (1994) Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation. Hum. Reprod., 9, 788-791.
4. Edelstein, M.C., Seltman, HJ., Cox, B.J. et al. (1990) Progesterone levels on the day of human chorionic gonadotrophin administration in cycles with gonadotrophin-releasing hormone agonist suppression are not predictive of pregnancy outcome. Fertil. Steril., 54, 853-857.
5. Fanchin, R., de Ziegler, D., Taieb, J. et al. (1993) Premature elevation of plasma progesterone alters pregnancy rates of in vitro fertilization and embryo transfer. Fertil. Steril., 59,1090-1094.
6. Givens, C.R., Schriock, E.D., Dandekar, P.V. and Martin, M. (1994) Elevated serum progesterone levels on the day of human chorionic gonadotrophin administration do not predict outcome in assisted reproduction cycles. Fertil. Steril., 62, 1011-1017.
7. Harada, T., Yoshida, S., Katagiri, C. et al. (1995) Reduced implantation rate associated with a subtle rise in serum progesterone concentration during the follicular phase of cycles stimulated with a combination of a GnRH-a and gonadotrophin. Hum. Reprod., 10, 1060-1064
8. Hofmann, G.E., Bergh, P.A., Guzman, I. et al. (1993) Premature luteinization is not eliminated by pituitary desensitization with leuprolide acetate in women undergoing gonadotrophin stimulation who demonstrated premature luteinization in a prior gonadotrophin-only cycle. Hum. Reprod., 8, 695-698.
9. Liu, J., Nagy, Z., Joris H. et al. (1994) Intracytoplasmic sperm injection does not require special treatment of the spermatozoa. Hum. Reprod., 9, 1127-1130.
10. Mannaerts, B., De Leeuw, R., Geelen, J. et al. (1991) Comparative in vitro and in vivo studies on the biological characteristics of recombinant human follicle-stimulating hormone. Endocrinology, 129, 2623-2630.
11. Olivennes, F., Fanchin, R., Bouchard, P. et al. (1995). Scheduled administration of a gonadotrophin-releasing hormone antagonist (Cetrorelix) on day 8 of in-vitro fertilization cycles: a pilot study. Hum. Reprod., 10, 1382-1386.
12. Shaw, R.W., Ndukwe, G., Imoedemhe, D.A. et al. (1985) Twin pregnancy after pituitary desensitization with LHRH agonist and pure FSH. Lancet, ii, 506-507.
13. Silverberg, K.M., Burns, W.N., Olive, D.L. et al. (1991) Serum progesterone levels predict success of in vitro fertilization/embryo transfer in patients stimulated with leuprolide acetate and human menopausal gonadotrophins. J. Clin. Endocrinol. Metab., 73, 797-803.
14. Smitz, J., Van Den Abbeel, E., Bollen, N. et al. (1992) The effect of gonadotrophin-releasing hormone (GnRH) agonist in the follicular phase on in vitro fertilization outcome in normo-ovulatory women. Hum. Reprod., 7, 1098-1102.
15. Ubaldi, F., Smitz, J., Wisanto, A. et al. (1995) Oocyte and embryo quality as well as pregnancy rate are not affected by high follicular phase serum progesterone. Hum. Reprod., 10, 102-108.
16. Ubaldi, F., Camus M., Smitz, J. et al. (1996) Premature luteinization in IVF cycles using gonadotrophin-releasing hormone agonist (GnRH-a) and recombinant follicle stimulating hormone (FSH) and GnRH-a and urinary FSH. Fertil. Steril., in press.
17. Van Steirteghem, A., Nagy, Z., Joris, H. et al. (1993) High fertilization and implantation rate after intracytoplasmic sperm injection. Hum. Reprod., 8, 1061-1066.